6:08 PM
 | 
Oct 26, 2012
 |  BC Extra  |  Company News

Amgen, Kleiner Perkins launch Atara

Amgen Inc. (NASDAQ:AMGN) and VC firm Kleiner Perkins Caufield & Byers launched newco Atara Biotherapeutics Inc. to develop six assets licensed from Amgen. The companies said the assets are...

Read the full 128 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >